Vaccines
As children in North Carolina head back to school, the North Carolina Department of Health and Human Services (DHHS) reminds families that vaccinations are an essential part of back-to-school success and overall health and well-being. According to Dr. Zack Moore, State Epidemiologist, following CDC recommendations to control the spread of
Vaccines
Research conducted at the Gene and Cell Therapy Center in Thessaloniki, Greece, has demonstrated that mRNA vaccines against COVID-19 continue to provide robust protection against SARS-CoV-2, even after long-term exposure. The study, published in Heliyon, found that immunocompetent individuals who received two doses of the BNT162b2 vaccine maintained a sustained
Vaccines
Research conducted by the Epidemiology and Disease Control (EDC) Clinic at Fort Bragg, North Carolina, revealed a significant gap in knowledge about human papillomavirus (HPV) infection among active duty soldiers. The study, published in Military Medicine, aimed to assess the effectiveness of an educational intervention in improving soldiers' knowledge
Vaccines
Researchers from the University of Pennsylvania compared the safety of different COVID-19 vaccines, including those from Pfizer, Moderna, and Janssen, using both randomized controlled trials (RCTs) and the Vaccine Adverse Event Reporting System (VAERS) data. The study aimed to identify the risks of severe adverse events (AEs) associated with these
Vaccines
Pregnant women in the UK are being encouraged to participate in a national COVID-19 vaccine study, which aims to determine the most effective use of booster vaccines during pregnancy. The Preg-CoV study is currently recruiting around 700 pregnant women across NIHR-supported sites in England. The study, led by researchers at
Vaccines
Researchers from the Jikei University School of Medicine in Tokyo, Japan, have conducted a study to evaluate the humoral response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine in kidney transplant recipients (KTRs). The study, published in Frontiers in Microbiology, found that the mortality rate due to
Vaccines
Children as young as six months can safely receive a second dose of the Pfizer-BioNTech SARS-CoV-2 mRNA vaccine, even after a suspected allergic reaction or a suspected allergy to polyethylene glycol (PEG) or polysorbate, according to a new study published in an official journal of the American Academy of Allergy,
COVID-19
Researchers from Emergency Clinical Hospital for Children in Bucharest, Romania, conducted a study to evaluate the reactogenicity and safety profile of the mRNA Pfizer-BioNTech COVID-19 vaccine among healthcare workers. The study involved an active survey conducted among the staff of a pediatric hospital in Bucharest, who were vaccinated with the
COVID-19
The High Potency APIs (HPAPIs) market is expected to grow at a significant rate, driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, and advancements in HPAPI manufacturing technologies. The market is projected to reach USD 39.6 billion by 2027 from USD 24.
Vaccines
Parents of children under five years old now have the option to vaccinate their infants and young children against COVID-19, following the Food and Drug Administration's (FDA) emergency authorization of Pfizer-BioNTech and Moderna mRNA-based COVID-19 vaccines for young children in June. The Centers for Disease Control and Prevention
Vaccines
The expansion of COVID-19 vaccinations to children under 6 years old, authorized by the U.S. Food and Drug Administration and Centers for Disease Control and Prevention, has been met with cautious optimism. The vaccines from Moderna and Pfizer/BioNTech have been shown to be safe, with similar side effects
Vaccines
Starting Tuesday, children under 5 years old will be able to receive COVID-19 vaccines at Dayton Children's Hospital, marking a significant milestone in the fight against the virus. This development comes after the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention authorized
